Drug Trial Radar · NCT00492960
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
Last checked: Nov 19, 2026Latest source record: Sep 20, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
171
Actual
Start
Aug 2007
Primary completion
Oct 2008
Study completion Mar 2009
Sponsor
- Lead sponsor
- 9 Meters Biopharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 27, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 72 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study was conducted to evaluate the efficacy of multiple doses of larazotide acetate in preventing intestinal permeability changes induced by a 6- week gluten challenge in subjects with celiac disease.
Conditions
- Celiac Disease
Interventions
larazotide acetateDrug
gelatin capsules
placeboDrug
gelatin capsules
900 mg glutenDietary supplement
gelatin capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of multiple doses larazotide acetate in preventing intestinal permeability changes induced by a 6- week gluten challenge.Time frame: Following ingestion of a solution of lactulose and mannitol; lactulose and mannitol excretion was quantified and the LAMA ratio calculated from overnight urine specimens collected on Days 7, 21, 35, 49 and 56.
Locations
23 sites in 2 countries. Site status is shown where the registry gives one.
Study Site
Scottsdale, Arizona
Study Site
Colorado Springs, Colorado
Study Site
Chicago, Illinois
Study Site
Lexington, Kentucky
Study Site
Hagerstown, Maryland
Study Site
Boston, Massachusetts
Study Site
Troy, Michigan
Study Site
Rochester, Minnesota
Study Site
New York, New York
Study Site
Asheville, North Carolina
Study Site
Cleveland, Ohio
Study Site
Philadelphia, Pennsylvania
Study Site
Pittsburgh, Pennsylvania
Study Site
Houston, Texas
Study Site
Plano, Texas
Study Site
Richmond, Virginia
Study Site
Seattle, Washington
Study Site
Calgary, Canada
Study Site
Montreal, Canada
Study Site
Toronto, Canada
Study Site
Winnipeg, Canada
Study Site
Edmonton, Alberta, Canada
Study Site
Kelowna, British Columbia, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.